Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: subjects will receive Quilting sutures and triamcinolone acetonide after ALND: a. For this group, the circulating nurse in OT will prepare a 10 ml syringe containing 2ml of 40mg/ml Tria
Sponsors
AIIMS PATNA
Eligibility
Inclusion criteria
Inclusion criteria: 1. All breast cancer patients who will undergo axillary lymph node dissection upto level II. 2. Patients willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Patient who has received prior radiation therapy to the axilla. 2. Patients with history of known allergy to drugs used. 3. Patient with acute or chronic infectious disease, autoimmune disorders, or intake of immunomodulating agents 4. Patients pregnant or lactating. 5. Patients with past or current history of lymphedema of limb on the affected side. 6. Patient with any prior surgery on the axillary lymphatic system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.It should be able to reduce cumulative axillary drain output post axillary lymph node dissection. 2.It should be able to allow the early removal of mechanical drains from axilla. Timepoint: 1. 30 days 2. 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.It should be able to minimize the number & volume of aspirations required to remove the collected fluid from axilla. 2. It should be able to reduce the incidence of surgical site infections.Timepoint: 30 DAYS | — |
Countries
India
Contacts
Public ContactDr Manisha
AIIMS PATNA
Outcome results
None listed